CN118922547A - 锌指降解决定子序列 - Google Patents

锌指降解决定子序列 Download PDF

Info

Publication number
CN118922547A
CN118922547A CN202380027768.5A CN202380027768A CN118922547A CN 118922547 A CN118922547 A CN 118922547A CN 202380027768 A CN202380027768 A CN 202380027768A CN 118922547 A CN118922547 A CN 118922547A
Authority
CN
China
Prior art keywords
zinc finger
finger domain
hybrid
amino acid
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380027768.5A
Other languages
English (en)
Chinese (zh)
Inventor
阿里·卡恩·萨利奥卢
安东尼厄斯·尼古拉斯·玛丽亚·舒马赫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Netherlands Cancer Institute
Original Assignee
Netherlands Cancer Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Netherlands Cancer Institute filed Critical Netherlands Cancer Institute
Publication of CN118922547A publication Critical patent/CN118922547A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/95—Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CN202380027768.5A 2022-03-18 2023-03-17 锌指降解决定子序列 Pending CN118922547A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL2031325 2022-03-18
NL2031325A NL2031325B1 (en) 2022-03-18 2022-03-18 Novel zinc finger degron sequences
PCT/NL2023/050136 WO2023177296A1 (en) 2022-03-18 2023-03-17 Zinc finger degron sequences

Publications (1)

Publication Number Publication Date
CN118922547A true CN118922547A (zh) 2024-11-08

Family

ID=82483007

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380027768.5A Pending CN118922547A (zh) 2022-03-18 2023-03-17 锌指降解决定子序列

Country Status (9)

Country Link
US (1) US20250206789A1 (https=)
EP (1) EP4493696A1 (https=)
JP (1) JP2025509853A (https=)
CN (1) CN118922547A (https=)
AU (1) AU2023233426A1 (https=)
CA (1) CA3255620A1 (https=)
IL (1) IL315649A (https=)
NL (1) NL2031325B1 (https=)
WO (1) WO2023177296A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2033636B1 (en) 2022-11-29 2024-06-04 Stichting Het Nederlands Kanker Inst Antoni Van Leeuwenhoek Ziekenhuis Receptor- and drug-dependent regulated on-site production of biologicals.
NL2037809B1 (en) 2024-05-29 2025-12-12 Cell Control Biotherapeutics Inc Loop reinforcement expression system for improved cell therapy products

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201710620D0 (en) 2017-07-03 2017-08-16 Glaxosmithkline Intellectual Property Ltd Targeted protein degradation
US12049482B2 (en) 2017-10-31 2024-07-30 The Brigham And Women's Hospital, Inc. Molecular switch-mediated control of engineered cells
WO2020132039A2 (en) 2018-12-18 2020-06-25 Dana-Farber Cancer Institute, Inc. Peptide tags for ligand induced degradation of fusion proteins
CN111907552B (zh) 2019-07-17 2021-08-13 中车大同电力机车有限公司 机车牵引装置及其调整方法
EP4048301B1 (en) 2019-10-23 2024-09-18 Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis Chimeric polypeptide for regulating immune cells
US20230151342A1 (en) 2020-02-28 2023-05-18 The Broad Institute, Inc Zinc finger degradation domains

Also Published As

Publication number Publication date
EP4493696A1 (en) 2025-01-22
NL2031325B1 (en) 2023-09-29
US20250206789A1 (en) 2025-06-26
WO2023177296A1 (en) 2023-09-21
AU2023233426A1 (en) 2024-10-31
JP2025509853A (ja) 2025-04-11
CA3255620A1 (en) 2023-09-21
IL315649A (en) 2024-11-01

Similar Documents

Publication Publication Date Title
TWI908706B (zh) ＣＡＲＴｙｒｉｎ組成物和使用方法
ES3051391T3 (en) Inducible caspases and methods for use
ES2862912T3 (es) Composición y procedimientos para la transferencia genética de alta eficiencia utilizando variantes de cápside de VAA
AU2020224373B2 (en) Hypoxia-responsive chimeric antigen receptors
BR112020012555A2 (pt) composições de vcar e métodos para uso
CN118922547A (zh) 锌指降解决定子序列
CN113710693B (zh) Dna结合结构域反式激活因子及其用途
TW202428311A (zh) 藉由與運鐵蛋白受體的相互作用實現ｃｎｓ範圍之基因傳遞的ａａｖ衣殼
JP2022105105A (ja) Ｐａｈ遺伝子移入のためのアデノ随伴ウイルス組成物及びそれらの使用方法
CN104080799A (zh) 具有病毒感染增强性质的肽及其用途
CN115552019A (zh) 在髓样细胞和小胶质细胞中特异性表达治疗性蛋白的病毒载体
KR20170098931A (ko) 뇌 질환을 치료하기 위한 방법 및 조성물
JP2023521867A (ja) 改変インターロイキン２２ポリペプチド及びその使用
WO2022081776A1 (en) Viral vector constructs for delivery of nucleic acids encoding cytokines and uses thereof for treating cancer
JP2026063215A (ja) 免疫細胞においてアルギニン濃度をモジュレートするための方法および組成物
JP7848138B2 (ja) 改変型上皮成長因子受容体及び細胞追跡におけるその使用
TW202221119A (zh) Dna結合域轉活化子及其用途
WO2024009280A1 (en) Integrated stress response inhibitors and methods of using the same
WO2020083916A1 (en) Virally expressed inhibitors of pdz domains, such as pick1 and uses thereof
JP7461687B2 (ja) 筋強直性ジストロフィー１型治療薬
JP2025541700A (ja) 受容体依存的及び薬剤依存的に調節されるオンサイトでの生物学的製剤の産生
CN121666392A (zh) 锌指肽、编码核酸、方法和用途
JP2023513211A (ja) タンパク質合成を増強するためのＣＲＩＳＰＲ－Ｃａｓ１３による標的ＲＮＡ翻訳
BR122025028353A2 (pt) Célula e seus usos, vetor ou transposon, car, composição e método para expressar um car na superfície de uma célula

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination